IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation
Open Access
- 21 May 2013
- journal article
- retracted article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5), e63588
- https://doi.org/10.1371/journal.pone.0063588
Abstract
Interleukin-26 (IL-26) is one of the cytokines secreted by Th17 cells whose role in human tumors remains unknown. Here, we investigated the expression and potential role of IL-26 in human gastric cancer (GC). The expression of IL-26 and related molecules such as IL-20R1, STAT1 and STAT3 was examined by real-time PCR and immunohistochemisty. The effects of IL-26 on cell proliferation and cisplatin-induced apoptosis were analyzed by BrdU cooperation assay and PI-Annexin V co-staining, respectively. Lentiviral mediated siRNA was used to explore its mechanism of action, and IL-26 related signaling was analyzed by western blotting. Human GC tissues showed increased levels of IL-26 and its related molecules and activation of STAT3 signaling, whereas STAT1 activation did not differ significantly between GC and normal gastric tissues. Moreover, IL-26 was primarily produced by Th17 and NK cells. IL-26 promoted the proliferation and survival of MKN45 and SGC-7901 gastric cancer cells in a dose-dependent manner. Furthermore, IL-20R2 and IL-10R1, which are two essential receptors for IL-26 signaling, were expressed in both cell lines. IL-26 activated STAT1 and STAT3 signaling; however, the upregulation of the expression of Bcl-2, Bcl-xl and c-myc indicated that the effect of IL-26 is mediated by STAT3 activation. Knockdown of STAT1 and STAT3 expression suggested that the proliferative and anti-apoptotic effects of IL-26 are mediated by the modulation of STAT1/STAT3 activation. In summary, elevated levels of IL-26 in human GC promote proliferation and survival by modulating STAT1/STAT3 signaling.Keywords
This publication has 33 references indexed in Scilit:
- MicroRNAs and STAT interplaySeminars in Cancer Biology, 2012
- Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in miceJCI Insight, 2011
- T helper 17 cell heterogeneity and pathogenicity in autoimmune diseaseTrends in Immunology, 2011
- Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cellsJCI Insight, 2011
- IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritisCurrent Opinion in Rheumatology, 2011
- NF-κB and STAT3 – key players in liver inflammation and cancerCell Research, 2010
- Interleukin-26: An IL-10-related cytokine produced by Th17 cellsCytokine & Growth Factor Reviews, 2010
- Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelingJCI Insight, 2009
- Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH17 cytokine interleukin-22Blood, 2009
- Th17 cells and mucosal host defenseSeminars in Immunology, 2007